Trials / Recruiting
RecruitingNCT05098340
Circulating circRNA in Acute Ischemic Stroke
Clinical Significance of Circulating circRNA in Acute Ischemic Stroke (CRAST)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
CRAST is to analyze the expression pattern of circular RNA (circRNA) by bioinformatics analysis in patients with acute ischemic stroke and healthy control. The candidate circRNA will be verified as biomarkers for the detection and prognosis of acute ischemic stroke.
Detailed description
Circular RNAs have been highlighted to be involved in the pathological process of ischemic stroke (IS). The purpose of this protocol will investigate the expression pattern of circular RNA (circRNA) by bioinformatics analysis in patients with acute ischemic stroke and healthy control. The candidate circRNA will be verified as biomarkers for the detection and prognosis of acute ischemic stroke. Distinctive expression patterns of circRNA will be identified by individual quantitative real time polymerase chain reaction (qRT-PCR). A diagnostic or predictive model will be established using logistic regression. The panel of these altered circRNAs may be associated with acute IS and could serve as a novel diagnostic or predictive method.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | Quantitative Real-time polymerase chain reaction | Quantitative Real-time polymerase chain reaction of circular RNA (circRNA). |
Timeline
- Start date
- 2020-10-01
- Primary completion
- 2024-10-30
- Completion
- 2024-10-30
- First posted
- 2021-10-28
- Last updated
- 2024-08-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05098340. Inclusion in this directory is not an endorsement.